{
}
Lumi AI, a UAE-based startup, has raised $3.7 million in seed funding to enhance its conversational analytics platform, enabling businesses to transform complex ERP and supply chain data into actionable insights without technical expertise. The platform allows users to generate customized reports through natural language queries, addressing inefficiencies in traditional business intelligence tools. With a diverse customer base and plans for expansion, Lumi AI aims to redefine data accessibility and empower organizations to make faster, data-driven decisions.
UBS has maintained a 'Buy' rating for Fresenius SE, setting a target price of 40 euros. Analyst Graham Doyle noted that US investors show indifference towards European medical technology manufacturers, with Fresenius shares currently valued higher than their US counterparts amid potential import duties.
The DAX 40 faces ongoing challenges from a tariff dispute, with significant US economic data on the horizon. Recent "JOLTs" data showed a sharp decline in job openings, while attention shifts to upcoming reports from China and ADP. The Bank of England will announce its interest rate decision on Thursday, and Friday's US labor market report is expected to reveal only 170,000 new jobs, down from December's 256,000.
US stock markets closed higher, buoyed by gains in technology stocks despite setbacks from Alphabet and AMD. The dollar showed slight gains against the franc and euro, while Asian equities rose following Wall Street's positive performance. Oil prices increased as Saudi Aramco raised March delivery prices amid rising demand from China and India.
The ongoing tariff dispute between the US and its trading partners continues to impact global investors, with a focus on upcoming US labor market data. Recent "JOLTs" data showed a significant drop in job openings, while the ADP employment report and ISM non-manufacturing index are also key indicators to watch. Additionally, the Bank of England's interest rate decision and the US labor market report on Friday are expected to influence market dynamics.
UBS recommends buying Swiss medtech stocks Alcon and Medacta, citing their growth potential despite short-term concerns for Alcon's 2025 forecasts. Alcon is expected to launch new products, while Medacta shows sustained growth in orthopaedics. Conversely, Straumann is rated sell due to high expectations and recent strong performance.
UBS AG has maintained a "Neutral" rating for Siemens Healthineers shares, setting a target price of 53 euros. Analyst Graham Doyle noted that the company needs to mitigate risks for its annual targets, which seems unlikely following a less significant first financial quarter. As of now, shares are trading at EUR 55.42, reflecting an 8.2% increase since the start of 2025, with Q1 2025 financial results expected on February 6, 2025.
UBS has maintained a "Neutral" rating for Siemens Healthineers, setting a target price of 53 euros. Analyst Graham Doyle noted that the company needs to mitigate risks associated with its annual targets, a challenge that may not be addressed in the upcoming first financial quarter.
UBS AG has maintained a "Neutral" rating for Siemens Healthineers, setting a target price of 53 euros. Analyst Graham Doyle noted that the company should reduce risks for its annual targets, which seems unlikely following a less significant first financial quarter. As of 10:41 am, Siemens Healthineers shares rose 0.8% to EUR 55.42, indicating a downside potential of 4.37% relative to the target price. The stock has increased by 8.2% since the start of 2025, with key figures for Q1 2025 expected to be released on February 6, 2025.
UBS AG has maintained a "Neutral" rating for Siemens Healthineers shares, setting a target price of 53 euros. Analyst Kavya Deshpande noted challenges in the Chinese diagnostics market for foreign players, which could hinder Siemens Healthineers' realignment efforts. Shares fell 0.7% to EUR 53.96, indicating a downside potential of 1.78% relative to the target price.
SIEMENS HEALTHINEERS
Companies
The information provided herein is generated by experimental artificial intelligence and is for informational purposes only.
lumi ai secures 3.7 million funding to transform supply chain analytics
19:55 26.03.2025
ubs maintains buy rating for fresenius with target price of 40 euros
11:10 11.02.2025
DAX 40 outlook amid tariff disputes and key US labor data ahead
14:25 10.02.2025
global markets react to us economic data and corporate earnings reports
Swiss Franc
Japanese Yen
Chinese Yuan
Euro
United States Dollar
NVIDIA Corporation
FMC Corp
Microsoft Corporation
Bank of America Corporation
Alphabet Inc.
Google Inc.
SIEMENS HEALTHINEERS
Broadcom Inc.
Amazon.com, Inc.
Leonteq AG
JPN
DEU
USA
GBR
CHE
Show more
06:20 06.02.2025
DAX 40 outlook amid tariff disputes and upcoming US labor data
17:19 04.02.2025
ubs recommends buying alcon and medacta in swiss medtech sector
Swiss Franc
ConvaTec Group PLC
Medacta Group SA
Alcon Inc.
Straumann Holding AG
SIEMENS HEALTHINEERS
DEU
CHE
Graham Doyle
Show more
12:00 04.02.2025
ubs maintains neutral rating for siemens healthineers with target price of 53 euros
12:17 31.01.2025
UBS maintains neutral rating for Siemens Healthineers with target price of 53 euros
11:10 31.01.2025
ubs maintains neutral rating for siemens healthineers with target price of 53 euros
10:58 31.01.2025
ubs maintains neutral rating for siemens healthineers with target price of 53 euros
15:18 24.01.2025
Trending
Subcategory
Corporate News
Stock Market Updates
Industry Trends
Industry Mergers & Acquisitions
Finance Mergers & Acquisitions
Domestic Politics
Banking Regulations
Global Financial Events
CEO Changes
Government Policies
Retail and Consumer Goods
Workplace Trends
Elections & Campaigns
Market Analysis and Predictions
Central Bank Actions
Global Trade Developments
Startups & Entrepreneurship
Hedge Funds & Private Equity
Banking & Investment Regulations
Corporate Social Responsibility
Countries:
Companies:
Tesla, Inc.
UniCredit S.p.A.
Banco BPM S.p.A.
Deutsche Bank Money Market PP
JPMorgan Chase & Co.
Barclays PLC
Credit Suisse Strategic Income I
Apple Inc.
CREDIT AGRICOLE
SpaceXCoin USD
Lloyds Banking Group plc
BNP Paribas SA
The Goldman Sachs Group, Inc.
Amazon.com, Inc.
UBS Group AG
Credit Agricole
Banco Santander, S.A.
Reinsurance Group of America, Incorporated
Amundi S.A.
Commerzbank AG
Currencies:
United States Dollar
Euro
British Pound Sterling
Swiss Franc
Chinese Yuan
Indian Rupee
Japanese Yen
South Korean Won
Offshore Chinese Yuan
Hong Kong Dollar
Norwegian Krone
Filipino Peso
Canadian Dollar
Singapore Dollar
Australian Dollar
Danish Krone
Swedish Krona
Mexican Peso
Qatari Riyal
South African Rand
People: